Crystal Amber Fund Ltd.
CRS · AIM · Financial Services · mcap £44m · 74.5p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 01 Oct 26 | Board change | Appointment of Non-Executive Director
("Crystal Amber Fund", the "Fund" or the "Company") |
+0.0% |
| 03 Aug 26 | Update on MMI and Further Investment
("Crystal Amber Fund", the "Fund" or the "Company") |
−0.6% | |
| 01 Jul 26 | Appointment of NOMAD and Broker
("Crystal Amber Fund", the "Fund" or the "Company") |
−1.5% | |
| 06 May 26 | Purchase of Ordinary Shares by Tarncourt
Further to the announcement on 31 March 2026 regarding the intended share purchase by Tarncourt Capital Limited ("Tarncourt"), the owner of the Company's new Investment Adviser, Tarncourt Asset Management Ltd, the Compan |
+0.0% | |
| 22 Apr 26 | Result of General Meeting
The Company announces that at the Extraordinary General Meeting held earlier today, all resolutions set out in the circular to shareholders dated 31 March 2026 (the "Circular") were duly passed. |
+0.0% | |
| 31 Mar 26 | Results | Half-year Results
For the six months ended 31 December 2025 |
+2.5% |
| 16 Feb 26 | Update on Morphic Medical Inc.
The Board of Crystal Amber is pleased to provide an update on Morphic Medical Inc. |
+2.0% | |
| 16 Jan 26 | Update and corrections regarding TVRs
The following announcement replaces the 'Update and corrections regarding total voting rights' announcement released on 16 January 2026 at 7:00 under RNS Number 1452P. |
+0.0% | |
| 16 Jan 26 | Update & corrections regarding total voting rights
("Crystal Amber Fund", the "Company" or the "Fund") |
+0.0% | |
| 12 Jan 26 | Cancellation of treasury shares
("Crystal Amber Fund", the "Company" or the "Fund") |
+0.0% | |
| 03 Dec 25 | Share Buyback Programme
("Crystal Amber Fund", the "Company" or the "Fund") |
+0.0% | |
| 20 Nov 25 | Share Buyback Programme
("Crystal Amber Fund", the "Company" or the "Fund") |
+1.6% | |
| 14 Nov 25 | Proposed change of strategy and investment manager
596/2014 to the extent it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended by virtue of the European Union (Withdrawal Agreement) Act 2020). |
+0.0% | |
| 20 Oct 25 | Share Buyback Programme
("Crystal Amber Fund", the "Company" or the "Fund") |
+0.7% | |
| 17 Oct 25 | Results | Final Results
Final results for the year ended 30 June 2025 |
+0.0% |
| 16 Oct 25 | Investor Presentation by Morphic Medical Inc
The Board of Crystal Amber is pleased to announce that Morphic Medical Inc. |
+0.0% | |
| 07 Oct 25 | Investor Presentation by Morphic Medical Inc
("Crystal Amber Fund", the "Company" or the "Fund") |
+0.0% |
Company filings. Not investment advice.